了解吾们

Company Introduction

太阳集团见好就收9728
太阳集团见好就收9728

Etana Biotechnologies Hong Kong Limited (EBHK) is the leading pharmaceutical company in Asia located in Hong Kong. As a strong industry leader with many well-known brands, EBHK has established a number of manufacturing bases in China (Shanghai and Zhuhai) and Indonesia that has an international scale and advanced technology cooperating with known pharmaceutical companies to develop new products and markets.

Shanghai United Cell Biotechnology Co., Ltd. (SUCB) established in 1995 is a wholly-owned subsidiary of EBHK. SUCB is engaged in manufacturing, R&D and sales of recombinant gene technology and vaccines. SUCB is located in the Pilot Free Trade Zone. The company has a total registered capital of USD 29.15 million, the total investment is 37.76 million, the factory occupies an area of 20,000 square meters and factory building area is 22000 square meters. The annual production capacity is 12.4 million vials for lyophilized powder for injection, 13 million cartridges, 10 million capsules and 4 million bags of capsules.

In 2015 with the increasing number of pharmaceutical products, market expansion and production lines, SUCB and Etana Biotech as a joint investment has set up Zhuhai United Biotechnology Co., Ltd (ZUCB) in Zhuhai High Technology Development Zone. The total registered capital is RMB 150 million yuan, total investment is RMB 330.2 million yuan, the factory location is in Zhuhai High Tech Development Zone Innovation Coast. In the future, SUCB will expand its Chinese business operations. SUCB uses its shareholder’s strong multinational presence to market in Asia, as a Chinese biotechnology product the goal is to become an international brand and eventually have more opportunities to go global.

Company History

太阳集团见好就收9728
  • 2018

    Launched of Ostiogen ?

  • 2014

    Launched of Pediatric format for OraVacs?

  • 2013

    GMP Certification of the New Plant (2010 version)

  • 2005

    Received IND approval for rhPTH (recombinant parathyroid hormone)

  • 2004

    Product Launch of OraVacs ?

  • 2002

    Product Launch Genheal ?

  • 2000

    Completion of the Shanghai Factory

  • 查看更好优质

Quality and Production

太阳集团见好就收9728

Quality Management and Production

SUCB has 5000 square meters production facility that has been approved by China’s GMP (Good Manufacturing Practice) 2010 version which includes workshops for gene process liquid raw material, vibrio cholera, lyophilized powder for injection, capsule preparation and solid preparation. Major equipments are state-of-the-art biotechnology instruments purchased domestically and imported from Europe to make sure that product quality is stable and reliable.

GMP Certifications and Quality Certificates

SUCB continuously adheres to a great importance of quality management that creates a healthy life and contributes to mankind. SUCB’s quality management system covers pharmaceutical production, inspection and distribution, continuously linking towards international standard. The independent quality assurance department closely monitors the implementation of the quality management system and strictly controls the entire process from material entering the facility to product release.

The National Drug Administration does random inspection checks and batch release inspection for vaccine products, SUCB’s random inspection quality performance rate and OraVacs?’ batch release inspection quality rate have reached 100百分比. Company’s production, quality and other technical personnel are all well trained professionals and regularly receives comprehensive professional and management training knowledge and skills to maintain technological improvement and management.

Honors and Awards

  • 太阳集团见好就收9728
    2014 Shanghai Pharmaceutical Industry Branded Product
  • 太阳集团见好就收9728
    People’s Choice for Best Enterprise
  • 太阳集团见好就收9728
    Philanthropist Award
XML 地图 | Sitemap 地图